Sign Up Today and Learn More About Ablative Solutions Stock
Invest in or calculate the value of your shares in Ablative Solutions or other pre-IPO companies through EquityZen's platform.
Ablative Solutions Stock (ABSO)
Ablative Solutions is a medical device firm that offers an alternative to surgical renal denervation for treating hypertension.
About Ablative Solutions Stock
Founded
2011
Headquarters
Kalamazoo, MI, US
Total Funding
120M
Industries
Science and Engineering, Health Care, Biotechnology
Ablative Solutions, Inc., was founded in 2011 by Tim Fischell, MD, FACC, and David Fischell, PhD, to address this significant unmet medical need. Ablative Solutions’ technology involves endovascular catheters to provide an efficacious, durable, cost-effective and safe alternative to surgical renal denervation for the treatment of hypertension and other diseases caused by an overactive sympathetic nervous system.
Ablative Solutions Press Mentions
Stay in the know about the latest news on Ablative Solutions
Peri-vascular tissue access catheter with locking handle
patents • Apr 02, 2025
Peri-vascular tissue ablation catheter with support structures
patents • Apr 02, 2025
Peri-vascular tissue ablation catheters
patents • Apr 02, 2025
Transvascular methods of treating extravascular tissue
patents • Feb 08, 2025
Peri-vascular tissue ablation catheters
patents • Feb 08, 2025
Ablative Solutions Management
Leadership team at Ablative Solutions
Founder
David R. Fischell
CEO & CMO, Board of Directors
Tim Fischell
Join now and verify your accreditation status to gain access to:
- Ablative Solutions Current Valuation
- Ablative Solutions Stock Price
- Ablative Solutions Management
- Available deals in Ablative Solutions and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Ablative Solutions Cap Table and Funding History by Share Class and Liquidity Preferences
- Ablative Solutions Revenue and Financials
- Ablative Solutions Highlights
- Ablative Solutions Business Model
- Ablative Solutions Risk Factors
- Ablative Solutions Research Report from SACRA Research
Trading Ablative Solutions Stock
How to invest in Ablative Solutions stock?
Accredited investors can buy pre-IPO stock in companies like Ablative Solutions through EquityZen funds. These investments are made available by existing Ablative Solutions shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Ablative Solutions stock?
Shareholders can sell their Ablative Solutions stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
